Literature DB >> 22037652

Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.

Frank Heinzelmann1, Daniela Thorwarth, Ulf Lamprecht, Theodor W Kaulich, Jörg Fuchs, Guido Seitz, Martin Ebinger, Rupert Handgretinger, Michael Bamberg, Martin Weinmann.   

Abstract

BACKGROUND AND
PURPOSE: Multimodality treatment approaches provide high local control and satisfying overall survival (OS) for children with localized bladder and/or prostate rhabdomyosarcoma (BP-RMS). However, current strategies including surgery and conventional radiotherapy are compromised by high rates of long-term genitourinary adverse effects. Therefore, a planning study combining organ preserving surgery with three different innovative adjuvant radiotherapy approaches was performed. PATIENTS AND METHODS: A case of a 21-month-old boy with BP-RMS treated with polychemotherapy according to the CWS 2002-P protocol, prostatectomy, partial cystectomy, and adjuvant high dose rate brachytherapy (HDR-BT) was used to perform a planning study comparing HDR-BT with intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) planning.
RESULTS: All modalities provide good coverage of the target volume and spare critical normal tissues. Rectum doses could be reduced by 2/3 using IMPT and by 1/3 using BT compared to IMRT. In terms of sparing the pelvis growth plates, BT and IMPT are also superior to IMRT.
CONCLUSION: All modalities provide good sparing of normal tissue. BT and IMPT are superior to IMRT with regard to doses on rectum and growth plates. BT is equivalent to IMPT in adequately selected tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037652     DOI: 10.1007/s00066-011-2261-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  47 in total

1.  German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results.

Authors:  Tobias Bölling; Andreas Schuck; Hildegard Pape; Christian Rübe; Frank-Michael Meyer; Carmen Martini; Beate Timmermann; Branka Asadpour; Rolf-Dieter Kortmann; Jörn D Beck; Thorsten Langer; Marios Paulides; Normann Willich
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

2.  Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected cases.

Authors:  Jan Muzik; Martin Soukup; Markus Alber
Journal:  Med Phys       Date:  2008-04       Impact factor: 4.071

3.  Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach.

Authors:  Normann Willich; Iris Ernst; Hildegard Pape; Christian Rübe; Beate Timmermann; Branka Asadpour; Rolf-Dieter Kortmann; Tobias Bölling
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

4.  [Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study].

Authors:  Tobias Bölling; Andreas Schuck; Christian Rübe; Stefan Hesselmann; Hildegard Pape; Karin Dieckmann; Barbara Pöllinger; Rolf-Dieter Kortmann; Irene Speiser-Held; Frank-Michael Meyer; Carmen Martini; Branka Asadpour; Beate Timmermann; Jörn D Beck; Thorsten Langer; Marios Paulides; Bernhard Schmidt; Normann Willich
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

5.  Response of growing bone to irradiation: a proposed late effects scoring system.

Authors:  P J Eifel; S S Donaldson; P R Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

6.  Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors.

Authors:  Sheri L Spunt; Teresa A Sweeney; Melissa M Hudson; Catherine A Billups; Matthew J Krasin; Allison L Hester
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

7.  Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer.

Authors:  Changlu Wang; Hidetsugu Nakayama; Shinji Sugahara; Takeji Sakae; Koichi Tokuuye
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

8.  Bladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy.

Authors:  D M Hays; R B Raney; W Lawrence; E H Soule; E A Gehan; M Tefft
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

9.  Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease.

Authors:  T J Kinsella; G Trivette; J Rowland; R Sorace; R Miller; B Fraass; S M Steinberg; E Glatstein; R J Sherins
Journal:  J Clin Oncol       Date:  1989-06       Impact factor: 44.544

10.  Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.

Authors:  Hélène Martelli; Christine Haie-Meder; Sophie Branchereau; Stéphanie Franchi-Abella; Maria-Rosa Ghigna; Isabelle Dumas; Nathalie Bouvet; Odile Oberlin
Journal:  J Pediatr Surg       Date:  2009-01       Impact factor: 2.545

View more
  4 in total

Review 1.  Progress in radiotherapy for pediatric sarcomas.

Authors:  Susan L McGovern; Anita Mahajan
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

Review 2.  Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma.

Authors:  Daniel D Shapiro; Miriam Harel; Fernando Ferrer; Patrick H McKenna
Journal:  Int Urol Nephrol       Date:  2016-04-11       Impact factor: 2.370

3.  Appraisal of the role of radical prostatectomy for rhabdomyosarcoma in children: oncological and urological outcome.

Authors:  Lorenzo Angelini; Gianni Bisogno; Ciro Esposito; Marco Castagnetti
Journal:  Ther Adv Urol       Date:  2018-03-07

4.  Clinical results of proton beam therapy for advanced neuroblastoma.

Authors:  Yoshiko Oshiro; Masashi Mizumoto; Toshiyuki Okumura; Shinji Sugahara; Takashi Fukushima; Hitoshi Ishikawa; Tomohei Nakao; Takayuki Hashimoto; Koji Tsuboi; Haruo Ohkawa; Michio Kaneko; Hideyuki Sakurai
Journal:  Radiat Oncol       Date:  2013-06-12       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.